Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats

Life Sciences

Volumn 77, Issue 18, 2005, Pages 2233-2245

  Takemori, Kumiko ^a   Ishida, Hiroyuki ^a   Ito, Hiroyuki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AT1 receptor; Cardiac hypertrophy; Nephrosclerosis; Stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HYDRALAZINE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; TCV 16; VASODILATOR AGENT;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NEPHROSCLEROSIS; NONHUMAN; PLASMA RENIN ACTIVITY; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CEREBRAL CORTEX; CEREBROVASCULAR ACCIDENT; HISTOCYTOCHEMISTRY; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; MALE; MYOCARDIUM; NEPHROSCLEROSIS; RATS; RATS, INBRED SHR; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 23844465280     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.12.048     Document Type: Article

References (29)

1. F.C. Barone, R.W. Coatney, S. Chandra, S.K. Sarkar, A.H. Nelson, L.C. Contino, D.P. Brooks, W.G. Campbell Jr., E.H. Ohlstein, and R.N. Willette Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats Cardiovascular Research 50 2001 525 537
2. T.M. Behr, R.N. Willette, R.W. Coatney, M. Berova, C.E. Angermann, K. Anderson, J.D. Sackner-Bernstein, and F.C. Barone Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease Journal of Hypertension 22 2004 583 592
3. E.L. Blezer, K. Nicolay, H.A. Koomans, and J.A. Joles Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats American Journal of Hypertension 14 1 2001 54 61
4. I. Gavras, and H. Gavras Angiotensin II as a cardiovascular risk factor Journal of Human Hypertension 16 Suppl. 2 2002 S2 S6
5. L. Gonzalez Bosc, M.L. Kurnjek, A. Muller, and N. Basso Effect of chronic angiotensin II inhibitor on the cardiovascular system of the normal rat American Journal of Hypertension 13 12 2000 1301 1307
6. S.B. Harrap, W.M. Van der Mervwe, S.A. Griffin, F. Macpherson, and A.F. Lever Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term Hypertension 16 16 1990 603 614
7. M. Horiuchi, K. Fujimura, T. Terashima, and T. Iso Method for determination of angiotensin-converting enzyme activity in blood and tissue by high-performance liquid chromatography Journal of Chromatography 233 1982 123 130
8. H. Ito, and T. Suzuki Pathophysiological overview of M-SHRSP. Progress in Hypertension H. Saito Y. Yamori M. Minami S.H. Parvez Progress in Hypertension vol. 3 1995 VSP Utrecht, Tokyo 1 19
9. H. Ito, M. Torii, and T. Suzuki A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium Comparative Biochemistry and Physiology. B 103 1 1992 37 40
10. H. Ito, M. Torii, and T. Suzuki A comparative study on lipid peroxidation in cerebral cortex of stroke-prone spontaneously hypertensive and normotensive rats International Journal of Biochemistry 25 2 1993 1801 1805
11. H. Ito, K. Takemori, J. Kawai, and T. Suzuki AT1 receptor antagonist prevents brain edema without lowering blood pressure Acta Neurochirurgica Supplementum 76 2000 141 145
12. H. Ito, K. Takemori, and T. Suzuki Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury Journal of Hypertension 19 3 Pt 2 2001 591 597
13. T. Ito, Y. Nishimura, and J. Saavedra Pre-treatment with candesartan protects from cerebral ischemia Journal of Renin Angiotensin Aldosterone System 2 3 2001 174 179
14. T. Ito, H. Yamakawa, C. Bregonzio, J.A. Terron, A. Falcon-Neri, and J.M. Saavedra Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist Stroke 33 9 2002 2297 2303
15. M. Jamaluddin, T. Meng, J. Sun, I. Boldogh, Y. Han, and A.R. Brasier Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kB activation Molecular Endocrinology 14 1 2000 99 113
16. Y. Kitami, T. Okura, R. Wakamiya, K. Marumoto, T. Iwata, and K. Hiwada Regulation of the gene expression of type-1 angiotensin II receptor in spontaneously hypertensive rats Blood Pressure 1 Suppl. 3 1992 12 16
17. H.C. Ledebur, and T.P. Parks Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kB site and p65 homodimers Journal of Biological Chemistry 270 2 1995 933 943
18. X.L. Ma, F. Gao, A.H. Nelson, B.L. Lopez, T.A. Christopher, T.L. Yue, and F.C. Barone Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats Journal of Pharmacology and Experimental Therapeutics 298 2001 879 885
19. H. Nakaya, H. Sasamura, M. Hayashi, and T. Saruta Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis American Society of Nephrology 12 4 2001 659 666
20. Y. Nishimura, T. Ito, K.L. Hoe, and J.M. Saavedra Chronic peripheral administration of the angiotensin II type 1 receptor antagonist candesartan blocks brain AT1 receptors Brain Research 871 1 2000 29 38
21. Y. Nishimura, T. Ito, and J.M. Saavedra Angiotensin II type 1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats Stroke 31 10 2000 2478 2486
22. H.M. Siragy, M. de Gasparo, M. El-Kersh, and R.M. Carey Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP Hypertension 38 2 2001 183 186
23. K. Takemori, H. Ito, and T. Suzuki Effects of inducible nitric oxide synthase inhibition on cerebral edema in severe hypertension Acta Neurochirurgica Supplementum 76 2000 335 338
24. K. Takemori, H. Ito, and T. Suzuki Effects of the AT1 receptor antagonist on adhesion molecule expression in leukocytes and brain microvessels of stroke-prone spontaneously hypertensive rats American Journal of Hypertension 13 11 2000 1233 1241
25. M. Torii, S. Inoue, S. Matsushima, S. Matsushima, S. Fuji, T. Maruyama, Y. Muraoka, and H. Ito Free radical injury in endothelial cells of spontaneously hypertensive rats aorta Journal of Toxicologic Pathology 7 1994 363 370
26. K. Tsutsumi, and J.M. Saavedra Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries American Journal of Physiology 261 3 Pt 2 1991 H667 H670
27. T. Unger Blood pressure lowering and renin-angiotensin system blockade Journal of Hypertension 21 Suppl. 6 2003 S3 S7
28. H. Yamakawa, M. Jezova, H. Ando, and J.M. Saavedra Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition Journal of Cerebral Blood Flow and Metabolism 23 3 2003 371 380
29. H. Zhang, X. Chen, X. Teng, C. Snead, and J.D. Catravas Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells Biochemical Pharmacology 55 11 1998 1873 1880